Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer

Peptide vaccine treatment has attracted attention in recent years as a new therapy option for chemotherapy-resistant, advanced, unresectable cancer. The safety of peptide vaccination with HLA-A(*)2402-restricted URLC10-A24-177 and VEGFR1-A12-9 1084 epitope peptides (fixed 2-mg dose) was investigated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HIGASHIHARA, YOSHIE, KATO, JUNKO, NAGAHARA, AKIHITO, IZUMI, KENTARO, KONISHI, MASAE, KODANI, TOMOHIRO, SERIZAWA, NOBUKO, OSADA, TARO, WATANABE, SUMIO
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2013
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3928476/
https://ncbi.nlm.nih.gov/pubmed/24398900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2013.2242
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge